Astrana Health, Inc.

ASTH

Astrana Health, Inc.

ASTH

Insider Sentiment (TTM):

Last Purchase:2022-06-17Last Sale:2022-06-17Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:29,563,220Shares Outstanding:48,946,399Institutional Ownership Pct.:60.40%

Earnings Market Reaction:

Filing Date:2026-05-08Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Management Consulting Services

ELVG BAH G FCN EXPO HURN

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Nonrelated Party	-	-	-	-	241	226	-0	12	120	77	29	67
Related Party	-	46	-	-	55	50	-0	12	120	59	29	67
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	478	429	462	340	259	288	348	325	335	294	274	294
Restricted Cash	-	-	-	-	-	-	-	-	-	-	-	0
Marketable Securities Current	-	-	1	2	2	2	2	2	2	2	3	4
Accounts Receivable Net Current	467	374	381	349	-	276	-	-	-	-	-	-
Income Taxes Receivable	0	2	0	8	16	19	16	22	0	11	-	-
Other Receivables Net Current	28	26	10	9	15	29	1	2	2	1	2	1
Prepaid Expense And Other Assets Current	26	26	23	22	24	25	21	17	17	17	14	15
Notes And Loans Receivable Net Current	5	5	6	-	-	0	-	-	-	-	-	-
Assets Current	1,004	863	884	729	613	638	597	570	539	462	476	465
Assets Noncurrent
Property Plant And Equipment Net	60	57	56	18	17	14	12	10	8	7	129	124
Intangible Assets Net Excluding Goodwill	257	271	285	106	112	118	109	116	120	72	74	74
Goodwill	875	865	863	417	416	419	410	410	410	279	276	274
Income Taxes Receivable Noncurrent	26	26	16	16	16	16	16	16	16	16	16	16
Notes And Loans Receivable Net Noncurrent	49	49	48	48	48	51	-	-	-	26	25	-
Equity Method Investments	27	26	18	38	38	39	35	33	36	26	44	46
Operating Lease Right Of Use Asset	34	36	34	31	31	33	33	29	39	37	21	18
Other Assets Noncurrent	27	23	23	30	31	17	9	9	4	2	9	7
Assets Noncurrent	1,355	1,355	1,354	713	718	716	688	682	687	472	597	562
Assets	2,359	2,219	2,237	1,442	1,331	1,355	1,285	1,252	1,226	933	1,073	1,027
Liabilities And Stockhold…
Liabilities Current
Restricted Cash Noncurrent	-	-	-	-	1	1	1	1	1	0	0	-
Accounts Payable And Accrued Liabilities Current	221	196	210	120	106	106	95	96	146	60	53	50
Taxes Payable Current	3	-	5	-	-	-	-	-	-	-	-	-
Liability For Claims And Claims Adjustment Expense	439	336	334	288	204	209	160	151	136	107	98	100
Accrued Income Taxes Current	-	-	-	-	-	-	-	-	6	0	30	20
Operating Lease Liability Current	8	8	7	5	5	5	5	5	5	5	4	3
Long Term Debt Current	48	48	48	13	13	9	15	17	21	20	3	3
Other Liabilities Current	23	24	22	30	28	27	30	32	32	19	8	-
Liabilities Current	745	615	630	460	361	366	313	310	355	219	203	186
Liabilities Noncurrent
Dividends Payable Current	-	-	-	-	1	1	1	1	1	1	1	1
Finance Lease Liability Current	-	-	-	-	0	1	1	1	1	1	1	1
Deferred Income Tax Liabilities Net	7	5	4	3	4	5	3	3	4	4	12	12
Operating Lease Liability Noncurrent	30	32	30	29	29	31	31	27	38	36	21	18
Long Term Debt Noncurrent	980	991	1,002	401	404	425	423	425	368	259	206	205
Other Liabilities Noncurrent	19	17	16	12	15	15	7	8	8	4	14	21
Liabilities Noncurrent	1,036	1,045	1,053	445	452	475	465	464	419	304	255	258
Mezzanine Equity
Temporary Equity Carrying Amount Including Portion…	-	-	-	-	-	-	-	-	-	-	18	14
Finance Lease Liability Noncurrent	-	-	-	-	1	1	1	1	1	1	1	1
Stockholders Equity Inclu…
Preferred Stock Value	0	-	0	0	-	-	-	-	-	-	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	478	471	473	463	452	426	411	402	395	371	363	357
Retained Earnings Accumulated Deficit	323	308	302	302	293	286	293	277	258	243	231	209
Stockholders Equity	815	793	789	765	750	717	710	683	658	617	598	570
Minority Interest	15	14	14	6	5	4	5	4	4	2	4	4
Liabilities And Stockholders Equity	2,359	2,219	2,237	1,442	1,331	1,355	1,285	1,252	1,226	933	1,073	1,027
Series A Preferred Stock	-	-	-	-	0	0	0	-0	0	1	0	0
Series B Preferred Stock	-	-	-	-	0	0	0	-0	0	1	0	0
Variable Interest Entity Not Primary Beneficiary	1,317	1,277	611	13	678	712	29	-46	718	541	33	-9
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	-	0.001	-	-
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	-	5	-	-
Preferred Stock Shares Issued	0	0	0	0	-	0	-	-	-	-	-	-
Preferred Stock Shares Outstanding	0	0	0	0	-	0	-	-	-	-	-	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	49	49	49	49	49	48	48	48	47	47	47	47
Shares Outstanding	49	49	49	49	49	48	48	48	47	47	47	47
Treasury Stock Common Shares	11	11	10	10	10	11	11	11	11	11	11	11
Liabilities	1,781	1,660	1,682	904	814	841	778	774	774	523	458	444

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-4.27%	13.26%	2.57%	-	-	-	-	-	-	-	-	-
2025	-16.56%	-16.76%	-21.68%	48.93%	38.30%	55.17%	-1.60%	12.44%	1.38%	7.74%	50.06%	61.81%
2024	6.09%	3.87%	33.67%	-0.25%	17.99%	16.22%	-3.50%	-25.01%	-14.08%	2.49%	10.74%	-15.51%
2023	3.43%	-3.13%	6.56%	-2.87%	-20.94%	-23.22%	14.29%	25.78%	15.86%	-11.92%	-17.36%	-9.19%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.35	1.40	1.40	1.59	1.70	1.75	1.91	1.84	1.52	2.11	2.35	2.50
Quick Ratio	1.31	1.36	1.37	1.54	1.63	1.68	1.84	1.78	1.47	2.03	2.28	2.42
Working Capital	258.73M	248.04M	253.70M	269.41M	252.00M	272.89M	284.06M	260.52M	183.54M	242.83M	273.27M	279.27M
Leverage & Debt
Debt to Equity	2.19	2.09	2.13	1.18	1.08	1.17	1.10	1.13	1.18	0.85	0.77	0.78
Interest Coverage TTM	1.47	1.57	1.50	2.22	2.43	2.70	2.78	3.76	4.52	5.25	7.63	9.42
Debt Ratio	0.76	0.75	0.75	0.63	0.61	0.62	0.61	0.62	0.63	0.56	0.43	0.43
Efficiency & Turnover
Asset Turnover TTM	1.91	1.78	1.64	1.80	1.76	1.78	1.46	1.40	1.31	1.46	1.32	1.31
Days Sales Outstanding TTM	48.38	37.31	48.04	52.62	-	49.51	-	-	-	-	-	-
Receivables Turnover TTM	7.54	9.78	7.60	6.94	-	7.37	-	-	-	-	-	-
Per Share Metrics
Diluted EPS TTM	-	-	-	-	-	-	-	-	-	-	1.04	-
Free Cash Flow Per Share TTM	3.17	2.14	1.96	2.47	1.06	0.92	1.46	1.04	0.92	0.85	2.40	1.31
Dividend Per Share TTM	0.05	0.16	0.17	0.17	0.19	0.08	1.31	1.35	1.33	1.34	0.05	0.02
Margin Metrics
Gross Profit Margin TTM	10.66%	10.73%	10.25%	11.30%	11.94%	13.34%	15.09%	16.28%	16.58%	15.50%	16.35%	17.01%
Operating Profit Margin TTM	2.45%	2.47%	2.10%	2.90%	3.55%	4.39%	4.92%	5.99%	6.35%	6.10%	7.61%	8.64%
Net Profit Margin TTM	0.82%	0.71%	0.24%	0.93%	1.56%	2.12%	3.37%	4.02%	4.10%	4.17%	3.69%	3.86%
Growth Metrics
Net Revenue Growth (1Y)	56.69%	56.39%	68.17%	51.97%	54.81%	46.72%	29.71%	22.76%	19.34%	21.19%	27.06%	35.75%
Net Income Growth (1Y)	-17.37%	-47.89%	-88.20%	-64.71%	-41.22%	-25.41%	18.44%	27.69%	33.71%	28.07%	40.38%	8.94%
EPS Growth (1Y)	-17.23%	-48.90%	-88.58%	-65.86%	-43.10%	-27.10%	15.38%	25.04%	30.98%	27.33%	35.55%	4.65%
Valuation Metrics
P/E TTM	41.49	53.94	204.62	54.18	43.43	35.02	47.75	30.16	33.46	31.01	29.34	29.38
P/B TTM	1.47	1.53	1.77	1.60	2.03	2.11	3.90	2.82	3.03	2.91	2.40	2.58
P/S TTM	0.34	0.38	0.48	0.51	0.68	0.74	1.61	1.21	1.37	1.29	1.08	1.13
Market Cap	1.20B	1.21B	1.40B	1.22B	1.52B	1.51B	2.77B	1.93B	1.99B	1.79B	1.44B	1.47B
Enterprise Value	1.74B	1.82B	1.99B	1.30B	1.68B	1.66B	2.86B	2.04B	2.05B	1.78B	1.37B	1.39B
Calculated Values
Free Cash Flow TTM	154.99M	104.49M	96.96M	121.24M	52.12M	44.17M	69.89M	49.50M	43.61M	39.70M	111.51M	61.13M
Net Debt	544.33M	604.72M	585.57M	73.21M	157.70M	146.13M	90.03M	116.64M	55.04M	-14.72M	-64.08M	-85.91M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2022-06-17Sale

Owner: Marsh, Linda

Title: -

Shares: 250,000

Price/Share: $37.00

Value: $9,250,000.00

Shares Owned: 270,081

Relationship: Director

Ownership: Indirect

2022-06-17Purchase

Owner: Allied, Physicians Of Cal…

Title: -

Shares: 250,000

Price/Share: $37.00

Value: $9,250,000.00

Shares Owned: 11,175,702

Relationship: TenPercentOwner

Ownership: Direct

2021-08-17Purchase

Owner: Allied, Physicians Of Cal…

Title: -

Shares: 40,000

Price/Share: $73.67

Value: $2,946,800.00

Shares Owned: 10,925,702

Relationship: TenPercentOwner

Ownership: Direct

2021-08-17Sale

Owner: Schmidt, David

Title: -

Shares: 40,000

Price/Share: $73.67

Value: $2,946,800.00

Shares Owned: -

Relationship: Director

Ownership: Direct

2021-06-15Sale

Owner: Young, Albert Waichow

Title: Chief Administrative Officer

Shares: 5,000

Price/Share: $48.58

Value: $242,900.00

Shares Owned: 1,110,265

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2022-06-17	Marsh, Linda	Director	-	Indirect	Sale	250,000	37.00	$9,250,000.00	270,081	4
2022-06-17	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	250,000	37.00	$9,250,000.00	11,175,702	4
2021-08-17	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	40,000	73.67	$2,946,800.00	10,925,702	4
2021-08-17	Schmidt, David	Director	-	Direct	Sale	40,000	73.67	$2,946,800.00	0	4
2021-06-15	Young, Albert Waichow	Officer	Chief Administrative Officer	Direct	Sale	5,000	48.58	$242,900.00	1,110,265	4
2021-05-13	Sim, Brandon	Officer	See Remarks	Direct	Purchase	1,000	31.40	$31,400.00	147,038	4
2021-04-28	Vazquez, Adrian	Officer	Chief Medical Officer	Direct	Sale	100,000	24.50	$2,450,000.00	371,004	4
2021-04-28	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	100,000	24.50	$2,450,000.00	10,887,594	4/A
2021-04-01	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Sale	1,638,045	24.50	$40,132,102.50	10,787,594	4/A
2020-09-14	Sim, Brandon	Officer	See Remarks	Direct	Purchase	1,000	17.20	$17,200.00	17,379	4
2020-09-14	Lam, Thomas S.	Director,Officer	President and Co-CEO	Indirect	Purchase	5,000	17.28	$86,400.00	690,490	4
2020-09-14	Sim, Kenneth T.	Director,Officer	Executive Chairman and Co-CEO	Indirect	Purchase	6,000	17.22	$103,320.00	42,996	4
2020-09-11	Vazquez, Adrian	Officer	Chief Medical Officer	Direct	Sale	602	18.00	$10,836.00	471,004	4
2020-09-10	Sim, Kenneth T.	Director,Officer	Executive Chairman and Co-CEO	Indirect	Purchase	5,000	17.60	$88,000.00	37,996	4/A
2020-09-10	Sim, Brandon	Officer	See Remarks	Indirect	Purchase	5,000	17.60	$88,000.00	37,996	4
2020-09-09	Lam, Thomas S.	Director,Officer	President and Co-CEO	Indirect	Purchase	5,000	17.85	$89,250.00	1,814,872	4
2020-09-09	Vazquez, Adrian	Officer	Chief Medical Officer	Direct	Sale	7,484	18.00	$134,712.00	471,606	4
2020-09-09	Sim, Kenneth T.	Director,Officer	Executive Chairman and Co-CEO	Indirect	Purchase	5,000	17.60	$88,000.00	37,996	4
2020-08-27	Lam, Thomas S.	Director,Officer	President and Co-CEO	Indirect	Purchase	5,000	18.23	$91,150.00	1,776,614	4
2020-08-27	Sim, Kenneth T.	Director,Officer	Executive Chairman and Co-CEO	Indirect	Purchase	5,000	18.34	$91,700.00	1,770,556	4
2020-08-27	Sim, Brandon	Officer	See Remarks, Item 2	Indirect	Purchase	5,000	18.34	$91,700.00	1,770,556	4/A
2020-08-27	Sim, Brandon	Director,Officer	See Remarks	Indirect	Purchase	5,000	18.34	$91,700.00	1,770,556	4
2020-06-11	Chin, Eric	Officer	Chief Financial Officer	Direct	Purchase	2,040	14.90	$30,396.00	9,197	4
2020-06-08	Vazquez, Adrian	Officer	Chief Medical Officer	Direct	Sale	4,200	17.09	$71,778.00	484,873	4
2020-06-03	Vazquez, Adrian	Officer	Chief Medical Officer	Direct	Sale	2,683	18.00	$48,294.00	518,258	4
2020-01-15	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	4,298	18.34	$78,825.32	17,307,214	4
2020-01-14	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	7,130	17.81	$126,985.30	17,302,916	4
2019-12-18	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	15,000	18.50	$277,500.00	17,290,317	4
2019-12-17	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	15,000	18.47	$277,050.00	17,275,317	4
2019-12-16	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	15,000	18.94	$284,100.00	17,260,317	4
2019-12-13	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	35,718	18.32	$654,353.76	17,245,317	4
2019-12-12	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	23,673	18.06	$427,534.38	17,209,599	4
2019-12-11	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	27,537	17.48	$481,346.76	17,185,926	4
2019-12-10	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	23,462	16.75	$392,988.50	17,064,939	4
2019-12-09	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	38,600	17.60	$679,360.00	17,041,477	4
2019-12-06	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	32,363	18.95	$613,278.85	17,002,877	4
2019-12-05	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	13,595	18.64	$253,410.80	16,970,514	4
2019-12-04	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	18,539	18.36	$340,376.04	16,956,919	4
2019-12-04	Eng, Michael F.	Director	-	Direct	Purchase	1,890	18.48	$34,927.20	4,890	4
2019-12-03	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	20,000	18.24	$364,800.00	16,938,380	4
2019-12-02	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	18,602	17.94	$333,719.88	16,918,380	4
2019-11-27	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	2,500	18.22	$45,550.00	16,893,278	4
2019-11-26	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	10,000	17.96	$179,600.00	16,890,778	4
2019-11-25	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	33,000	17.32	$571,560.00	16,880,778	4
2019-11-22	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	25,000	17.79	$444,750.00	16,847,778	4
2019-11-21	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	1,900	17.50	$33,250.00	16,822,778	4
2019-11-20	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	12,100	17.28	$209,088.00	16,820,878	4
2019-11-19	Allied, Physicians Of Cal…	TenPercentOwner	-	Direct	Purchase	18,203	16.17	$294,342.51	16,808,778	4
2019-11-14	Sim, Kenneth T.	Director,Officer	Executive Chairman and Co-CEO	Indirect	Purchase	10,000	14.67	$146,700.00	1,737,561	4
2019-11-14	Lam, Thomas S.	Director,Officer	President and Co-CEO	Indirect	Purchase	10,000	14.84	$148,400.00	1,743,623	4
2019-10-08	Sim, Kenneth T.	Director,Officer	Executive Chairman and Co-CEO	Indirect	Purchase	5,000	15.55	$77,750.00	1,727,561	4
2019-09-13	Vazquez, Adrian	Officer	Chief Medical Officer	Direct	Sale	27,350	19.77	$540,709.50	520,941	4
2019-09-12	Eng, Michael F.	Director	-	Direct	Purchase	2,000	20.28	$40,560.00	3,000	4
2019-08-19	Eng, Michael F.	Director	-	Direct	Purchase	1,000	15.97	$15,970.00	1,000	4
2019-08-16	Sim, Kenneth T.	Director,Officer	Executive Chairman	Indirect	Purchase	2,500	16.32	$40,800.00	1,663,678	4
2019-08-15	Lam, Thomas S.	Director,Officer	Chief Executive Officer	Indirect	Purchase	10,000	15.88	$158,800.00	1,674,740	4
2019-08-14	Young, Albert Waichow	Officer	Co-Chief Medical Officer	Direct	Purchase	5,000	15.01	$75,050.00	916,446	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

60.40%

Inst. Shares: 29,563,220

Shares Outstanding: 48,946,399

2025-12-31

58.37%

Inst. Shares: 28,533,476

Shares Outstanding: 48,885,358

2025-09-30

53.39%

Inst. Shares: 26,364,906

Shares Outstanding: 49,383,857

2025-06-30

51.66%

Inst. Shares: 25,385,480

Shares Outstanding: 49,138,631

2025-03-31

52.80%

Inst. Shares: 25,888,284

Shares Outstanding: 49,028,624

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	29,563,220	48,946,399	60.40%
2025-12-31	28,533,476	48,885,358	58.37%
2025-09-30	26,364,906	49,383,857	53.39%
2025-06-30	25,385,480	49,138,631	51.66%
2025-03-31	25,888,284	49,028,624	52.80%
2024-12-31	25,236,082	47,929,872	52.65%
2024-09-30	24,256,640	47,780,523	50.77%
2024-06-30	22,654,670	47,541,549	47.65%
2024-03-31	21,976,474	47,458,264	46.31%
2023-12-31	21,606,987	46,547,502	46.42%
2023-09-30	20,971,876	46,547,502	45.05%
2023-06-30	20,345,062	46,547,502	43.71%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Astrana Health, Inc. (ASTH) — SEC Financial Statements & Analysis

Astrana Health, Inc. (ASTH) is a services-management consulting services company, incorporated in DE. Astrana Health, Inc. trades on Nasdaq as: ASTH. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Astrana Health, Inc. reported a 56.69% year-over-year revenue growth, a Gross Profit Margin of 10.66% (TTM), a Debt-to-Equity ratio of 2.19x, a Price-to-Sales (P/S) ratio of 0.34x (TTM), a Price-to-Book (P/B) ratio of 1.47 (TTM), at a market cap of $1.20B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 56.69%
Gross Profit Margin TTM: 10.66%
Debt To Equity: 2.19x
P/S TTM: 0.34x
P/B TTM: 1.47
Market Cap: $1.20B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Astrana Health, Inc. in?

Astrana Health, Inc. (ASTH) operates in the Services-Management Consulting Services industry.

What is ASTH's market cap?

Astrana Health, Inc. (ASTH) has a market capitalization of $1.20B as of 2026-03-31.

What is ASTH's P/E ratio?

Astrana Health, Inc. (ASTH)'s trailing twelve month P/E ratio is 41.49x as of 2026-03-31.

What exchange does ASTH trade on?

Astrana Health, Inc. (ASTH) trades on the Nasdaq.

Where is Astrana Health, Inc. incorporated?

Astrana Health, Inc. is incorporated in DE.

Astrana Health, Inc. (ASTH) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.